Shanghai Kinetic Medical Co., Ltd (300326.SZ)
CNY 6.83
(1.19%)
CNY 6.83
(1.19%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 284.11 Million | 236.75 Million | 378.15 Million | 284.92 Million | 255.6 Million | 95.25 Million |
| Net Income | 112.53 Million | -23.95 Million | 174.99 Million | -124.95 Million | 303.08 Million | 460.36 Million |
| Depreciation & Amortization | 77.99 Million | 261.95 Million | 209.37 Million | 33.06 Million | 30.66 Million | 35.21 Million |
| Deferred income taxes | -1.13 Million | -2.95 Million | 1.31 Million | -4.14 Million | 3.15 Million | -10.61 Million |
| Stock-based compensation | - | 2.95 Million | -26.98 Million | 25.66 Million | 11.1 Million | 2.51 Million |
| Change in working capital | 100.11 Million | -76.86 Million | 24.42 Million | -50.04 Million | -150.31 Million | -121.59 Million |
| Other non-cash items | 50.46 Million | 75.61 Million | -30.63 Million | 426.85 Million | 72.17 Million | -278.72 Million |
| Investing Cash Flow | -198.51 Million | -163.77 Million | -109.21 Million | -322.74 Million | -299.18 Million | 324.51 Million |
| Investments in PPE | -53.78 Million | -41.45 Million | -49.21 Million | -29.6 Million | -40.34 Million | -37.77 Million |
| Acquisitions | 9.85 Million | 1.39 Million | -34.22 Million | -128.74 Million | -51.03 Million | 250.34 Million |
| Investment purchases | -946 Million | -75.21 Million | -89.32 Million | -337.73 Million | -192 Million | -24.5 Million |
| Sales/Maturities of investments | 791.42 Million | 38.25 Million | 65.01 Million | 271.55 Million | 19.9 Million | 11.6 Million |
| Other Investing Activities | -101.29 Million | -86.76 Million | -1.47 Million | -98.21 Million | -35.71 Million | 124.83 Million |
| Financing Cash Flow | -174.91 Million | -104.09 Million | -238.95 Million | -83.47 Million | -178.21 Million | 299.55 Million |
| Debt repayment | -150.89 Million | -197.79 Million | -441.43 Million | -376.28 Million | -340.35 Million | -297.4 Million |
| Dividends payments | -5.11 Million | -35.53 Million | -35.86 Million | -56.08 Million | -50.55 Million | -42.21 Million |
| Common Stock Repurchased | - | -16.4 Million | -13.78 Million | - | -86.96 Million | - |
| Common Stock Issuance | - | 16.4 Million | 13.78 Million | - | 41.39 Million | - |
| Other Financing Activities | -4.6 Million | 140.93 Million | 257.33 Million | 348.9 Million | 283.72 Million | 639.17 Million |
| Accounts receivables | -214.8 Million | 149.92 Million | 45.61 Million | 145.51 Million | -153.01 Million | -131.56 Million |
| Accounts payables | 336.81 Million | -174.18 Million | 38.1 Million | -175.62 Million | 51.75 Million | 87.6 Million |
| Inventory | -21.89 Million | -49.65 Million | -60.62 Million | -15.79 Million | -52.2 Million | -67.01 Million |
| Other working capital | 335.68 Million | -2.95 Million | 1.32 Million | -4.14 Million | 3.15 Million | -54.57 Million |
| Cash at beginning of period | 707.49 Million | 721.76 Million | 694.8 Million | 826.14 Million | 1.04 Billion | 327.24 Million |
| Cash at end of period | 620.43 Million | 702.62 Million | 721.76 Million | 694.8 Million | 826.14 Million | 1.04 Billion |
| Capital Expenditure | -53.78 Million | -41.45 Million | -49.21 Million | -29.6 Million | -40.34 Million | -37.77 Million |
| Effect of forex changes on cash | 1.67 Million | 11.97 Million | -3.02 Million | -10.04 Million | 2.14 Million | -768.87 Thousand |
| Net cash flow / Change in cash | -87.05 Million | -19.13 Million | 26.95 Million | -131.33 Million | -219.65 Million | 718.54 Million |
| Free Cash Flow | 230.32 Million | 195.3 Million | 328.94 Million | 255.31 Million | 215.26 Million | 57.47 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 25.82 Million | 19.36 Million | 10.87 Million | -16.62 Million | 112.53 Million | 14.45 Million |
| Depreciation & Amortization | - | 19.42 Million | 19.42 Million | 21.49 Million | 77.99 Million | 21.49 Million |
| Deferred income taxes | - | - | - | - | -1.13 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -33.37 Million | - | -236.69 Million | 100.11 Million | -127.3 Million |
| Other non-cash items | 35.76 Million | 54.52 Million | -28.37 Million | 146.94 Million | 50.46 Million | -15.72 Million |
| Investing Cash Flow | -280.32 Million | 18.8 Million | -245.84 Million | -70.52 Million | -198.51 Million | 69.62 Million |
| Investments in PPE | -25.48 Million | -17.7 Million | -12.91 Million | -20.96 Million | -53.78 Million | -17.86 Million |
| Acquisitions | 149.2 Thousand | 2.25 Million | 71.19 Thousand | 9.78 Million | 9.85 Million | 475 Thousand |
| Investment purchases | 782.74 Million | -792.74 Million | -17 Million | -903.19 Million | -946 Million | -10 Million |
| Sales/Maturities of investments | 3.36 Million | 611 Million | 1.99 Million | 791.42 Million | 791.42 Million | 806.72 Thousand |
| Other Investing Activities | -258.2 Million | 216 Million | -216 Million | 52.43 Million | -101.29 Million | 96.2 Million |
| Financing Cash Flow | 34.52 Million | -21.89 Million | 9.31 Million | -32.53 Million | -174.91 Million | -134.55 Million |
| Debt repayment | -81.27 Million | -22.92 Million | -15 Million | -18.19 Million | -150.89 Million | -188.53 Million |
| Dividends payments | -43.87 Million | -224.65 Thousand | -880.68 Thousand | -1.23 Million | -5.11 Million | -676.18 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -2.86 Million | 12.52 Million | -5.68 Million | 5.06 Million | -4.6 Million | 54.65 Million |
| Accounts receivables | - | -23.2 Million | - | -214.8 Million | -214.8 Million | -93.39 Million |
| Accounts payables | - | - | - | - | 336.81 Million | - |
| Inventory | - | -13.32 Million | - | -21.89 Million | -21.89 Million | -25.31 Million |
| Other working capital | - | 3.15 Million | - | - | - | -8.6 Million |
| Cash at beginning of period | 412.57 Million | 366.58 Million | 620.43 Million | 615.28 Million | 707.49 Million | 682.37 Million |
| Cash at end of period | 225.06 Million | 412.57 Million | 366.58 Million | 620.43 Million | 620.43 Million | 615.28 Million |
| Capital Expenditure | -25.48 Million | -17.7 Million | -12.91 Million | -20.96 Million | -53.78 Million | -17.86 Million |
| Effect of forex changes on cash | -1.9 Million | 60.49 Thousand | 186.01 Thousand | -6.03 Million | 1.67 Million | 1.71 Million |
| Net cash flow / Change in cash | -187.51 Million | 45.99 Million | -253.84 Million | 5.15 Million | -87.05 Million | -67.09 Million |
| Free Cash Flow | 36.1 Million | 36.76 Million | -30.42 Million | 87.85 Million | 230.32 Million | -19.12 Million |
002119
RHIM
HFCL
GBLX
MOTILALOFS
SVRS